CHICAGO–(BUSINESS WIRE)–The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the fourth quarter of 2025 payable on February 13, 2026, to all shareholders of record as of January 9, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a trusted … [Read more…]
MOUNT ROYAL, N.J.–(BUSINESS WIRE)–#AHSAZ–The American Headache Society® (AHS), a professional society of healthcare providers dedicated to the study and treatment of headache and face pain, will host the 2025 Scottsdale Headache Symposium December 4-7 in Scottsdale, Arizona. This year’s meeting brings together physicians, scientists, and advanced practitioners for an immersive educational experience designed to elevate … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Phenindione (CAS 83-12-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. This report on Phenindione provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves … [Read more…]
Elevance Health is making healthcare more intuitive and personalized using technology to simplify access and build trust. Elevance Health’s affiliated health plans are building loyalty through connection and ongoing support. Digital tools address member pain points by providing clear, accurate, and personalized information. INDIANAPOLIS–(BUSINESS WIRE)–Saurabh Tandon, Elevance Health’s chief experience officer, shared his thoughts on … [Read more…]
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that, following the conclusion of the American Society of Hematology (ASH) Annual Meeting and Exposition, the company will hold a virtual investor event on Thursday, December 11, 2025, to highlight key Hematology programs. The company will host a webcast beginning at 9:00 a.m. ET, which is … [Read more…]
Poxel’s recovery plan has been finalised: Main objectives: accelerating commercial development and partnership-seeking activities for Imeglimine outside Japan, PXL 770 and PXL 065, significantly reducing the Company’s costs, and clearing the Company’s liabilities. It was developed with the support of its long-standing financial partner IPF. IPF and IRIS have committed to providing the Company with … [Read more…]
Not intended for UK Media OCEANIC-STROKE demonstrates superiority of asundexian with antiplatelet therapy, showing significant reduction in ischemic stroke risk, without increasing ISTH major bleeding rate, compared to placebo with antiplatelet therapy OCEANIC-STROKE is the first successfully completed Phase III study of a Factor XIa inhibitor Bayer will globally engage with health authorities in preparation … [Read more…]
ANDOVER, Mass.–(BUSINESS WIRE)–Transmural Systems, a leader in pioneering electrosurgical structural heart therapies, obtained 510(k) clearance from the United States Food and Drug Administration (FDA) for TELLTALE – the first and only cleared and dedicated electrosurgical guidewire system to prevent coronary obstruction in patients undergoing Transcatheter Aortic Valve Replacement (TAVR) for both native aortic stenosis and … [Read more…]
ATCC, industry, government, advocacy, and academic leaders met with NSCEB Commissioners for pivotal discussions on the critical role of authenticated biomaterials in a secure and resilient bioeconomy MANASSAS, Va.–(BUSINESS WIRE)–#Biomanufacturing—ATCC, the world’s premier private, non-profit biological resources and standards organization, hosted an event today, Empowering the Future of Biotechnology Through Trusted Science, with the National … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Graft Versus Host Disease (GvHD) Treatment – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market for Graft Versus Host Disease (GvHD) Treatment was valued at US$2.9 Billion in 2024 and is projected to reach US$4.5 Billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030. … [Read more…]
